title: End-stage renal disease in a bodybuilder: a multifactorial process or simply doping?
authors.affiliation: Department of Internal Medicine IV, Friedrich-Schiller-University of Jena, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Hartung
authors.forename: J
authors.initials: J
authors.lastname: Gerth
authors.forename: R
authors.initials: R
authors.lastname: Fünfstück
authors.forename: H J
authors.initials: HJ
authors.lastname: Gröne
authors.forename: G
authors.initials: G
authors.lastname: Stein
mesh_terms: D000318:Adrenergic beta-Agonists / Q000009:adverse effects; D000328:Adult; D045930:Anabolic Agents / Q000009:adverse effects; D002976:Clenbuterol / Q000008:administration & dosage; D004300:Doping in Sports; D015444:Exercise; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000473:pathology; D008297:Male; D012307:Risk Factors
chemical_list: D000318:Adrenergic beta-Agonists; D045930:Anabolic Agents; D002976:Clenbuterol